FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab
Published inJournal of Bone and Mineral Research, vol. 33, no. 7, p. 1219-1226
Publication date2018
Affiliation
Research group
Citation (ISO format)
COSMAN, Felicia et al. FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. In: Journal of Bone and Mineral Research, 2018, vol. 33, n° 7, p. 1219–1226. doi: 10.1002/jbmr.3427
Main files (1)
Article (Published version)
Identifiers
- PID : unige:107112
- DOI : 10.1002/jbmr.3427
ISSN of the journal0884-0431